Real-time PCR based on the recN and gyrB genes was developed to detect four Streptococcus bovis/Streptococcus equinus complex (SBEC) subspecies from rectal swab specimens. The overall prevalence was 35.2%: Streptococcus gallolyticus subsp. gallolyticus (11.1%), S. gallolyticus subsp. pasteurianus (13%), Streptococcus infantarius subsp. coli (20.4%), and S. infantarius subsp. infantarius (11.1%). To conclude, these real-time PCR assays provide a reliable molecular method to detect SBEC pathogenic subspecies from rectal swab specimens.
I
n an attempt to define the taxonomy of the Streptococcus bovis/ Streptococcus equinus complex (SBEC), researchers have proposed renaming S. bovis biotypes as Streptococcus gallolyticus subsp. gallolyticus (S. bovis biotype I), Streptococcus infantarius subsp. infantarius (S. bovis biotype II/1), Streptococcus infantarius subsp. coli (S. bovis biotype II/1), and Streptococcus gallolyticus subsp. pasteurianus (S. bovis biotype II/2) (1, 2).
S. bovis bacteremia has been found to be related to colorectal cancer (CRC) for more than 30 years (3) . Results have suggested that S. gallolyticus sp. is more frequently related to both endocarditis and colonic lesions than S. infantarius sp. (4, 5) . Nevertheless, S. infantarius sp. is associated with noncolonic cancer, such as cancer of the pancreas and biliary tract, generally appearing as cholangitis (6) .
Authors have claimed that different S. bovis subspecies should be named according to the classification proposed by Schlegel et al. (2) both in clinical practice and in scientific publications, which implies the use of molecular techniques for the subclassification of SBEC (7) . Recently, the use of a partial recN gene sequence was explored in order to investigate taxonomy and phylogeny in the genus Streptococcus, and other genes (16S rRNA, groEL, gyrB, rpoB, and sodA) were compared to recN: interspecies and intrasubspecies similarities of recN and gyrB were lower (8) .
Therefore, our aim was to use the recN and gyrB genes as targets to develop useful real-time PCR assays to detect S. gallolyticus subsp. gallolyticus, S. gallolyticus subsp. pasteurianus, S. infantarius subsp. coli, and S. infantarius subsp. infantarius from rectal swab specimens in individuals that underwent colonoscopy. The first assay is based on recN, which detects S. gallolyticus subsp. gallolyticus and S. gallolyticus subsp. pasteurianus. The second assay specifically detects S. infantarius subsp. coli and S. infantarius subsp. infantarius based on gyrB.
A total of 19 bacterial strains were evaluated in this study and are listed in Table 1 . All five clinical isolates were identified using the technique of matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) by using the Vitek MS system (bioMérieux, Marcy l'Etoile, France) ( Table 1) . Growth culture strains were resuspended in 500 l of ultrapurified water and lysed by boiling for 15 min. Cells were pelleted, and the supernatant was separated and stored at Ϫ20°C.
Rectal swab specimens were collected in accordance with ethical guidelines established by the Ethical Principles for Medical Research Involving Human Subjects (Declaration of Helsinki, 1964 ) and stored at Ϫ80°C. All subjects gave written informed consent, and the study protocol was approved by our local Institutional Ethical Committee. In a period ranging from June to September 2011, 54 rectal swab specimens were obtained from subjects who underwent colonoscopy at Santa Clara Hospital endoscopy service. Santa Clara Hospital is a general hospital in Porto Alegre, Brazil. Each swab (ESwab; Copan, Brescia, Italy) was suspended in 1 ml of modified liquid Amies medium and stored at Ϫ80°C. DNA isolation was performed using the BioPur Mini Spin extraction kit (Biometrix, Curitiba, Brazil).
Partial recN and gyrB nucleotide sequences were analyzed using the BLASTN algorithm to compare the sequences to a database. Afterwards, primers and fluorescent dye-labeled TaqMan MGB probes were designed using the Primer Express v3.0 software program (Applied Biosystems, Foster City, CA). The sequences of primers and probes and product sizes are listed in Table 2 . A TaqMan 6-carboxytetramethylrhodamine (TAMRA) real-time PCR assay based on the ␤-globin gene (Applied Biosystems, Foster City, CA) was used for an internal control.
PCRs for the presence/absence of the recN and gyrB genes were carried out with 4 l of extracted DNA and 10 l of master mix, 800 nM (each) primer, and 200 nM probes. DNA was amplified using the StepOnePlus real-time PCR system (Applied Biosystems, Foster City, CA). All reaction conditions included an initial denaturation of 95°C for 10 min, followed by amplifications using 40 cycles of 95°C for 15 s and 60°C for 1 min. The positive specimens were determined as follows: amplification yielded a positive result, and the threshold cycle (C T ) deviation for the replicate was not higher than 0.5, with a C T cutoff at 35.
Five clinical isolates and four reference strains (Table 1) were correctly identified using the primer and probe sets designed in these real-time PCR assays. No false-positive amplification reactions were observed when the real-time PCR assays were evaluated against various closely related Streptococcus species, Enterococcus species, and Escherichia coli ( Table 2) . We ensured adequate primer and probe specificity by alignment of partial sequences retrieved from the GenBank database.
Fifty In the present study, two TaqMan-MGB real-time PCR assays were designed to specifically detect subspecies of the SBEC based on sequence analysis of the recN and gyrB genes. To our knowledge, these are the first applicable real-time PCR assays to detect all clinically significant SBEC subspecies. Recently, a multiplex PCR/restriction fragment length polymorphism (RFLP) assay based on 16S rRNA proposed SBEC species identification of isolates from dairy microbial communities. However, this assay was not able to discriminate at the subspecies level (9) . Previously, a group developed a PCR/RFLP assay based on groESL for the identification of SBEC subspecies evaluated in reference strains and clinical isolates (10) . The combination of excellent sensitivity and specificity, low contamination risk, ease of performance, and speed has made real-time PCR an appealing alternative in the clinical microbiology laboratory (11) . These real-time PCR assays could be useful for SBEC subspecies identification in different clinical samples, such as blood, cerebrospinal fluid, and colonic tissues. We determined that 35.2% of the 54 subjects were colonized with SBEC subspecies, actually S. bovis. This fecal carriage rate is higher than those observed in prior studies (3, 12, 13) . Notably, a recently published study (14) showed that the fecal carriage rate of SBEC subspecies was 4.6% among adult subjects with tumorous lesions, nontumorous lesions, and normal colonoscopy results. Those authors used a biomolecular technique and identified SBEC subspecies in the feces of 12 of 259 subjects, with the following distribution: S. lutetiensis (S. infantarius subsp. coli, n ϭ 9; S. gallolyticus subsp. pasteurianus, n ϭ 2; and S. gallolyticus subsp. gallolyticus, n ϭ 1 (14) . Our results were in agreement with theirs, with S. infantarius subsp. coli (formerly S. bovis biotype II) being the most commonly identified subspecies (20.4%), and the S. gallolyticus subsp. gallolyticus and S. gallolyticus subsp. pasteurianus fecal carriage rates were similar (11.1% and 13%, respectively). We identified almost half of SBEC-colonized subjects as having concomitant colonization with two or three subspecies. This finding has not been reported previously, possibly due to the fact that in most former studies, fecal culturing was performed for bacterial isolation. We analyzed clinical samples directly after collection of rectal swab specimens; therefore, underestimation of the actual fecal carriage rate was greatly minimized.
The use of molecular techniques for the subclassification of S. bovis/S. equinus complex bacteria is required in order to fully understand the clinical value of SBEC subspecies infections/colonization as early signaling of colonic malignancy or other gastrointestinal diseases (7, 15) .
In summary, these real-time PCR assays provide a reliable molecular method to detect SBEC subspecies and quantify S. gallolyticus species from rectal swab specimens. These assays might be a useful tool for screening for and surveillance of colonization by this bacterial complex in individuals subjected to a routine colonoscopy.
